Przejdź do zawartości
Merck

TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma.

Cell reports (2018-06-28)
Karthiga Santhana Kumar, Anuja Neve, Ana S Guerreiro Stucklin, Claudia M Kuzan-Fischer, Elisabeth J Rushing, Michael D Taylor, Dimitra Tripolitsioti, Lena Behrmann, Daniel Kirschenbaum, Michael A Grotzer, Martin Baumgartner
ABSTRAKT

The microenvironment shapes cell behavior and determines metastatic outcomes of tumors. We addressed how microenvironmental cues control tumor cell invasion in pediatric medulloblastoma (MB). We show that bFGF promotes MB tumor cell invasion through FGF receptor (FGFR) in vitro and that blockade of FGFR represses brain tissue infiltration in vivo. TGF-β regulates pro-migratory bFGF function in a context-dependent manner. Under low bFGF, the non-canonical TGF-β pathway causes ROCK activation and cortical translocation of ERK1/2, which antagonizes FGFR signaling by inactivating FGFR substrate 2 (FRS2), and promotes a contractile, non-motile phenotype. Under high bFGF, negative-feedback regulation of FRS2 by bFGF-induced ERK1/2 causes repression of the FGFR pathway. Under these conditions, TGF-β counters inactivation of FRS2 and restores pro-migratory signaling. These findings pinpoint coincidence detection of bFGF and TGF-β signaling by FRS2 as a mechanism that controls tumor cell invasion. Thus, targeting FRS2 represents an emerging strategy to abrogate aberrant FGFR signaling.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Anti-ROCK2 Antibody, from rabbit, purified by affinity chromatography
Sigma-Aldrich
Anti-MYO10 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Monoclonal Anti-α-Tubulin antibody produced in mouse, clone DM1A, ascites fluid
Sigma-Aldrich
Anti-Nuclei Antibody, clone 3E1.3, clone 3E1.3, Chemicon®, from mouse
Sigma-Aldrich
Anti-FRS2/SNT-1 Antibody, Upstate®, from mouse